102 related articles for article (PubMed ID: 8189054)
1. Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice.
Durandy A; Emilie D; Peuchmaur M; Forveille M; Clement C; Wijdenes J; Fischer A
J Immunol; 1994 Jun; 152(11):5361-7. PubMed ID: 8189054
[TBL] [Abstract][Full Text] [Related]
2. Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes.
Foussat A; Wijdenes J; Bouchet L; Gaidano G; Neipel F; Balabanian K; Galanaud P; Couderc J; Emilie D
Eur Cytokine Netw; 1999 Dec; 10(4):501-8. PubMed ID: 10586116
[TBL] [Abstract][Full Text] [Related]
3. Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies.
Durandy A; Brousse N; Rozenberg F; De Saint Basile G; Fischer AM; Fischer A
J Clin Invest; 1992 Sep; 90(3):945-52. PubMed ID: 1326002
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes.
Fior R; Vita N; Raphael M; Minty A; Maillot MC; Crevon MC; Caput D; Biberfeld P; Ferrara P; Galanaud P
Eur Cytokine Netw; 1994; 5(6):593-600. PubMed ID: 7727691
[TBL] [Abstract][Full Text] [Related]
5. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
6. Endogenous secretion of IL-4 maintains growth and Thy-1 expression of a transformed B cell clone.
Louie SW; Ramirez LM; Krieg AM; Maliszewski CR; Bishop GA
J Immunol; 1993 Jan; 150(2):399-406. PubMed ID: 8093458
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N
Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322
[TBL] [Abstract][Full Text] [Related]
8. Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma.
Campo S; Serlupi-Crescenzi O; Arseni B; Rossi S; Saggio I; Salone B; Cherubini G; Carminati P; De Santis R
Cytokine; 2005 Sep; 31(5):368-74. PubMed ID: 16061391
[TBL] [Abstract][Full Text] [Related]
9. The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes.
Airoldi I; Guglielmino R; Carra G; Corcione A; Gerosa F; Taborelli G; Trinchieri G; Pistoia V
Haematologica; 2002 Apr; 87(4):434-42. PubMed ID: 11940489
[TBL] [Abstract][Full Text] [Related]
10. Production and roles of IL-6, IL-10, and IL-13 in B-lymphocyte malignancies and in B-lymphocyte hyperactivity of HIV infection and autoimmunity.
Emilie D; Zou W; Fior R; Llorente L; Durandy A; Crevon MC; Maillot MC; Durand-Gasselin I; Raphael M; Peuchmaur M; Galamaud P
Methods; 1997 Jan; 11(1):133-42. PubMed ID: 8990099
[TBL] [Abstract][Full Text] [Related]
11. Model of angiogenesis in mice with severe combined immunodeficiency (SCID) and xenoengrafted with Epstein-Barr virus-transformed B cells.
Woodford NL; Call DR; Remick DG; Rochford R
Comp Med; 2004 Apr; 54(2):209-15. PubMed ID: 15134368
[TBL] [Abstract][Full Text] [Related]
12. Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
Bohlen H; Manzke O; Titzer S; Lorenzen J; Kube D; Engert A; Abken H; Wolf J; Diehl V; Tesch H
Cancer Res; 1997 May; 57(9):1704-9. PubMed ID: 9135012
[TBL] [Abstract][Full Text] [Related]
13. B-cell-derived IL-10: production and function.
Burdin N; Rousset F; Banchereau J
Methods; 1997 Jan; 11(1):98-111. PubMed ID: 8990095
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.
de Kroon JF; de Paus RA; Kluin-Nelemans HC; Kluin PM; van Bergen CA; Munro AJ; Hale G; Willemze R; Falkenburg JH
Exp Hematol; 1996 Jul; 24(8):919-26. PubMed ID: 8690051
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6-mediated growth enhancement of cell lines derived from pyothorax-associated lymphoma.
Kanno H; Yasunaga Y; Iuchi K; Yamauchi S; Tatekawa T; Sugiyama H; Aozasa K
Lab Invest; 1996 Aug; 75(2):167-73. PubMed ID: 8765317
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
Loomis R; Carbone R; Reiss M; Lacy J
Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752
[TBL] [Abstract][Full Text] [Related]
17. Expression of the IL-6 gene induces differentiation of a human monoclonal EBV-transformed B cell line.
Jochems GJ; Bende RJ; Klein MR; Zeijlemaker WP; van Lier RA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):124-33. PubMed ID: 8395233
[TBL] [Abstract][Full Text] [Related]
18. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines.
Beatty PR; Krams SM; Martinez OM
J Immunol; 1997 May; 158(9):4045-51. PubMed ID: 9126962
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.
Stewart JP; Behm FG; Arrand JR; Rooney CM
Virology; 1994 May; 200(2):724-32. PubMed ID: 8178456
[TBL] [Abstract][Full Text] [Related]
20. Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice.
Hilbert DM; Theisen PW; Rudikoff EK; Bauer SR
Oncogene; 1998 Oct; 17(16):2125-35. PubMed ID: 9798684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
